Back to Search Start Over

Biological Evaluation of a Fluorescent-Imaging Agent for Medullary Thyroid Cancer in an Orthotopic Model.

Authors :
Rossfeld, Kara K
Justiniano, Steven E
Ding, Haiming
Gong, Li
Kothandaraman, Shankaran
Sawant, Dwitiya
Saji, Motoyasu
Wright, Chadwick L
Kirschner, Lawrence S
Ringel, Matthew D
Tweedle, Michael F
Phay, John E
Source :
The Journal of Clinical Endocrinology & Metabolism; September 2017, Vol. 102 Issue: 9 p3268-3277, 10p
Publication Year :
2017

Abstract

The primary and definitive treatment of medullary thyroid cancer (MTC) is surgical resection. Recurrent or residual disease is typically a result of incomplete surgical removal.

Details

Language :
English
ISSN :
0021972X and 19457197
Volume :
102
Issue :
9
Database :
Supplemental Index
Journal :
The Journal of Clinical Endocrinology & Metabolism
Publication Type :
Periodical
Accession number :
ejs51161639
Full Text :
https://doi.org/10.1210/jc.2017-00573